Istradefylline 40 mg/day increased peak levels and AUC of CYP3A4 substrates in clinical trials. This effect was not observed with istradefylline twenty mg/working day. Consider dose reduction of delicate CYP3A4 substrates. Use of this Web-site and any information contained herein is governed thro